オンボディインジェクターの市場規模、シェア、動向分析レポート：技術別、用途別、最終用途別、地域別、セグメント別予測、2024年～2030年

オンボディインジェクター市場の成長と動向：

Grand View Research, Inc.の最新レポートによると、オンボディインジェクターの世界市場規模は、2024年から2030年にかけて14.9%のCAGRを記録し、2030年までに127億米ドルに達すると予測されています。

体内注射器は、使いやすく、痛みが少なく、頻繁に病院を訪れることなく長時間の薬剤投与を可能にすることで、患者の服薬アドヒアランスを向上させる。このような利点により、オンボディインジェクターの人気が高まっています。さらに、医療インフラが整備され、先進医療機器の導入が進んでいるアジア太平洋などの地域は、予測期間中に市場が成長する大きな機会を提供しています。

注射針の刺し傷に対する懸念の高まりや、注射針の挿入、薬剤の調製、注射針のカバーと廃棄に関連するリスクを排除することによって患者と医療従事者の両方の安全性を高める必要性、さらにがんなどの慢性疾患の有病率の増加は、予測期間中の市場成長を促進すると予想される要因の一部です。

WHOの国際がん研究機関（IARC）によると、2022年には約2,000万人ががんと診断され、約970万人ががんで死亡しています。いくつかのがんやその他の慢性疾患の治療では、長期間にわたって頻繁に薬を注射する必要があります。オンボディインジェクターは、従来の通院や自己注射に比べ、患者がこれらの薬剤を受け取るのに便利で、混乱が少ない可能性のある代替手段を提供します。

オンボディインジェクター市場レポートハイライト

• 技術別では、スプリング式が2023年に40.89%の最大売上シェアを占めたが、これはその安定した圧力と速度が正確な投与を保証するためです。
• 技術別では、ロータリーポンプは、投薬の高い制御性、投薬ミスのリスクの最小化、治療効果の最大化により、予測期間中に15.1%のCAGRで急成長が見込まれています。
• 用途別では、頻繁な投与が必要な2型糖尿病の有病率の高さから、糖尿病分野が2023年に最大の売上シェアを占めました。
• 用途別では、多発性硬化症、関節リウマチ、炎症性腸疾患（IBD）などの慢性自己免疫疾患の有病率の上昇により、自己免疫疾患分野が最も速いCAGRで成長すると予想されます。
• 糖尿病、自己免疫疾患、がんなどの慢性疾患を管理するための薬剤の自己投与に対する嗜好の高まりにより、最終用途に基づくと、2023年には在宅ケア分野が最大の収益シェアを占めました。
• 2023年には、北米が33.17％のシェアを占めました。これは、主要市場プレイヤーの存在、在宅ケアへのシフトの増加、先進的な体内注射器へのアクセスの向上が要因です。

目次

第1章 調査手法と範囲

第2章 エグゼクティブサマリー

第3章 オンボディインジェクター市場の変数、動向、範囲

• 市場系統の見通し
  • 親市場の見通し
  • 関連/付随市場の見通し
• 市場力学
  • 市場 促進要因分析
  • 市場抑制要因分析
• オンボディインジェクター市場分析ツール
  • 業界分析- ポーターのファイブフォース分析
  • PESTEL分析

第4章 オンボディインジェクター市場：技術別推定・動向分析

• セグメントダッシュボード
• オンボディインジェクター市場：技術別変動分析
• オンボディインジェクター市場：技術別展望
• 2018年から2030年までの市場規模と予測および動向分析
• スプリングベース
• モーター駆動
• ロータリーポンプ
• 拡張バッテリー
• その他

第5章 オンボディインジェクター市場：用途別推定・動向分析

• セグメントダッシュボード
• オンボディインジェクター市場：用途別変動分析
• オンボディインジェクター市場：用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 腫瘍学
• 糖尿病
• 心血管疾患
• 自己免疫疾患
• その他

第6章 オンボディインジェクター市場：最終用途別推定・動向分析

• セグメントダッシュボード
• オンボディインジェクター市場：最終用途別変動分析
• オンボディインジェクター市場：最終用途別展望
• 2018年から2030年までの市場規模と予測および動向分析
• 病院・クリニック
• 在宅ケア環境
• その他

第7章 オンボディインジェクター市場：地域別推定・動向分析

• 地域ダッシュボード
• オンボディインジェクター市場：地域別変動分析
• オンボディインジェクター市場：技術、用途、最終用途別の地域推定・動向分析
• 2018年から2030年までの市場規模と予測および動向分析
• 北米
  • 北米のオンボディインジェクター市場推計・予測、2018年-2030年
  • 米国
  • カナダ
  • メキシコ
• 欧州
  • 欧州のオンボディインジェクター市場推計・予測、2018年-2030年
  • 英国
  • ドイツ
  • フランス
  • イタリア
  • スペイン
  • デンマーク
  • スウェーデン
  • ノルウェー
• アジア太平洋
  • アジア太平洋地域のオンボディインジェクター市場推計・予測、2018年-2030年
  • 日本
  • 中国
  • インド
  • 韓国
  • オーストラリア
  • タイ
• ラテンアメリカ
  • ラテンアメリカのオンボディインジェクター市場推計・予測、2018年-2030年
  • ブラジル
  • アルゼンチン
• 中東・アフリカ
  • 中東およびアフリカのオンボディインジェクター市場推計・予測、2018年-2030年
  • 南アフリカ
  • サウジアラビア
  • アラブ首長国連邦
  • クウェート

第8章 競合情勢

• 市場参入企業の分類
• 主要企業プロファイル
  • West Pharmaceutical Services, Inc.
  • BD
  • Stevanato Group
  • Enable Injections
  • Nemera
  • Debiotech SA
  • AbbVie, Inc.
  • Coherus BioSciences, Inc.
  • Gerresheimer AG
  • E3D Elcam Drug Delivery Devices

List of Tables

• Table 1 List of Secondary Sources
• Table 2 List of Abbreviations
• Table 3 Global on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 4 Global on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 5 Global on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 6 North America on-body injectors market, by region, 2018 - 2030 (USD Million)
• Table 7 North America on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 8 North America on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 9 North America on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 10 U.S. on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 11 U.S. on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 12 U.S. on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 13 Canada on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 14 Canada on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 15 Canada on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 16 Mexico on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 17 Mexico on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 18 Mexico on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 19 Europe on-body injectors market, by country, 2018 - 2030 (USD Million)
• Table 20 Europe on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 21 Europe on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 22 Europe on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 23 UK on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 24 UK on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 25 UK on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 26 Germany on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 27 Germany on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 28 Germany on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 29 France on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 30 France on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 31 France on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 32 Italy on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 33 Italy on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 34 Italy on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 35 Spain on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 36 Spain on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 37 Spain on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 38 Norway on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 39 Norway on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 40 Norway on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 41 Sweden on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 42 Sweden on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 43 Sweden on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 44 Denmark on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 45 Denmark on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 46 Denmark on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 47 Asia Pacific on-body injectors market, by country, 2018 - 2030 (USD Million)
• Table 48 Asia Pacific on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 49 Asia Pacific on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 50 Asia Pacific on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 51 Japan on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 52 Japan on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 53 Japan on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 54 China on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 55 China on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 56 China on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 57 India on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 58 India on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 59 India on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 60 Australia on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 61 Australia on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 62 Australia on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 63 South Korea on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 64 South Korea on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 65 South Korea on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 66 Thailand on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 67 Thailand on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 68 Thailand on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 69 Latin America on-body injectors market, by country, 2018 - 2030 (USD Million)
• Table 70 Latin America on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 71 Latin America on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 72 Latin America on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 73 Brazil on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 74 Brazil on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 75 Brazil on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 76 Argentina on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 77 Argentina on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 78 Argentina on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 79 Middle East & Africa on-body injectors market, by country, 2018 - 2030 (USD Million)
• Table 80 Middle East & Africa on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 81 Middle East & Africa on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 82 Middle East & Africa on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 83 South Africa on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 84 South Africa on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 85 South Africa on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 86 Saudi Arabia on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 87 Saudi Arabia on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 88 Saudi Arabia on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 89 UAE on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 90 UAE on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 91 UAE on-body injectors market, by end use, 2018 - 2030 (USD Million)
• Table 92 Kuwait on-body injectors market, by technology, 2018 - 2030 (USD Million)
• Table 93 Kuwait on-body injectors market, by application, 2018 - 2030 (USD Million)
• Table 94 Kuwait on-body injectors market, by end use, 2018 - 2030 (USD Million)

List of Figures

• Fig. 1 Information Procurement
• Fig. 2 Primary Research Pattern
• Fig. 3 Market Research Approaches
• Fig. 4 Value Chain-Based Sizing & Forecasting
• Fig. 5 Market Formulation & Validation
• Fig. 6 On-body injectors market segmentation
• Fig. 7 Market driver analysis (Current & future impact)
• Fig. 8 Market restraint analysis (Current & future impact)
• Fig. 9 SWOT Analysis, By Factor (Political & Legal, Economic and Technological)
• Fig. 10 Porter's Five Forces Analysis
• Fig. 11 On-body injectors market, technology outlook key takeaways (USD Million)
• Fig. 12 On-body injectors market: Technology movement analysis (USD Million), 2023 & 2030
• Fig. 13 Spring-based market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 14 Motor-driven market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 15 Rotary pump market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 16 Expanding battery market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 17 Other market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 18 On-body injectors market, application outlook key takeaways (USD Million)
• Fig. 19 On-body injectors market: Application movement analysis (USD Million), 2023 & 2030
• Fig. 20 Oncology market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 21 Diabetes market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 22 Cardiovascular disease market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 23 Autoimmune disease market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 24 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 25 On-body injectors market, end use outlook key takeaways (USD Million)
• Fig. 26 On-body injectors market: End use movement analysis (USD Million), 2023 & 2030
• Fig. 27 Hospitals & clinics market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 28 Home care settings market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 29 Others market revenue estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 30 On-body injectors market: Regional key takeaways (USD Million)
• Fig. 31 On-body injectors market: Regional outlook, 2023 & 2030, USD Million
• Fig. 32 North America on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 33 U.S. on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 34 Canada on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 35 Mexico on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 36 Europe on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 37 UK on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 38 Germany on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 39 France on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 40 Spain on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 41 Italy on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 42 Sweden on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 43 Norway on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 44 Denmark on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 45 Asia Pacific on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 46 China on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 47 Japan on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 48 India on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 49 South Korea on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 50 Australia on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 51 Thailand on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 52 Latin America on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 53 Brazil on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 54 Argentina on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 55 Middle East and Africa on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 56 South Africa on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 57 Saudi Arabia on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 58 UAE on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 59 Kuwait on-body injectors market estimates and forecasts, 2018 - 2030 (USD Million)
• Fig. 60 List of key emerging company's/technology disruptors/innovators

On-body Injectors Market Growth & Trends:

The global on-body injectors market size is expected to reach USD 12.7 billion by 2030, registering a CAGR of 14.9% from 2024 to 2030, according to a new report by Grand View Research, Inc. The on-body injectors increase patient adherence to medication by offering easy-to-use, less pain and enabling extended drug administration without frequent hospital visits. These advantages of on-body injectors are significantly increasing their popularity. Moreover, regions such as Asia Pacific, with developing healthcare infrastructure and rising adoption of advanced medical devices, offer huge opportunities for market growth over the forecast period.

The increasing concerns over needle stick injuries and the need to increase the safety for both patients and healthcare professionals by eliminating risks associated with needle insertion, drug preparation, and covering & disposing of needles, coupled with the increasing prevalence of chronic diseases such as cancer are some of the factors expected to drive the market growth over the forecast period.

According to the WHO agency International Agency for Research on Cancer (IARC), around 20 million people were diagnosed with cancer, and around 9.7 million mortalities occurred due to cancer in 2022. Several cancers and other chronic disease treatments require frequent injections of medications over extended periods. On-body injectors offer a convenient and potentially less disruptive alternative for patients to receive these medications compared to traditional hospital visits or self-administered injections, which can significantly increase their demand over the forecast period.

On-body Injectors Market Report Highlights:

• Based on the technology, the spring-based segment accounted for the largest revenue share of 40.89% in 2023 owing to their consistent pressure and speed, which ensures precise dosing
• Based on technology, the rotary pump segment is expected to grow at the fastest CAGR of 15.1% during the forecast period owing to the high control offered by them in dispensing medications, minimizing the risk of dosing errors and maximizing therapeutic efficacy
• Based on the application, the diabetes segment accounted for the largest revenue share in 2023 due to the high prevalence of type 2 diabetes, which requires frequent administration
• Based on the application, the autoimmune diseases segment is expected to grow at the fastest CAGR owing to the rising prevalence of chronic autoimmune conditions such as multiple sclerosis, rheumatoid arthritis, and Inflammatory Bowel Diseases (IBD)
• Based on the end use, the homecare segment accounted for the largest revenue share in 2023 owing to the growing preference for self-administration of medications for managing chronic conditions such as diabetes, autoimmune disorders, and cancer in homecare settings
• In 2023, North America dominated with a share of 33.17%, driven by the presence of key market players, an increasing shift toward home care, and better access to advanced on-body injectors

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.1. Segment Definitions
  • 1.1.1. Technology
  • 1.1.2. Application
  • 1.1.3. End Use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecasts timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
    • 1.3.5.1. Data for primary interviews in North America
    • 1.3.5.2. Data for primary interviews in Europe
    • 1.3.5.3. Data for primary interviews in Asia Pacific
    • 1.3.5.4. Data for primary interviews in Latin America
    • 1.3.5.5. Data for Primary interviews in MEA
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
  • 1.6.2. Approach 1: Commodity flow approach
  • 1.6.3. Volume price analysis (Model 2)
  • 1.6.4. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Technology outlook
  • 2.2.2. Application outlook
  • 2.2.3. End Use outlook
  • 2.2.4. Regional outlook
• 2.3. Competitive Insights

Chapter 3. On-body Injectors Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing prevalence of chronic diseases
    • 3.2.1.2. Technological advancements
    • 3.2.1.3. Patient preference and compliance
    • 3.2.1.4. Increasing focus on home healthcare
    • 3.2.1.5. Increasing concerns about needlestick injuries
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High cost compared to alternatives
• 3.3. On-body Injectors Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political landscape
    • 3.3.2.2. Economic landscape
    • 3.3.2.3. Social landscape
    • 3.3.2.4. Technological landscape
    • 3.3.2.5. Environmental landscape
    • 3.3.2.6. Legal landscape

Chapter 4. On-body Injectors Market: Technology Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. On-body Injectors Market: Technology Movement Analysis
• 4.3. On-body Injectors Market by Technology Outlook (USD Million)
• 4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 4.5. Spring-based
  • 4.5.1. Spring-based Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.6. Motor-driven
  • 4.6.1. Motor-driven Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.7. Rotary Pump
  • 4.7.1. Rotary Pump Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.8. Expanding Battery
  • 4.8.1. Expanding Battery Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 4.9. Other
  • 4.9.1. Other Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. On-body Injectors Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. On-body Injectors Market: Application Movement Analysis
• 5.3. On-body Injectors Market by Application Outlook (USD Million)
• 5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 5.5. Oncology
  • 5.5.1. Oncology Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.6. Diabetes
  • 5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.7. Cardiovascular Disease
  • 5.7.1. Cardiovascular Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.8. Autoimmune Disease
  • 5.8.1. Autoimmune Disease Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 5.9. Others
  • 5.9.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. On-body Injectors Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. On-body Injectors Market: End Use Movement Analysis
• 6.3. On-body Injectors Market by End Use Outlook (USD Million)
• 6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 6.5. Hospitals & Clinics
  • 6.5.1. Hospitals & Clinics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.6. Home Care Settings
  • 6.6.1. Home Care Settings Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
• 6.7. Others
  • 6.7.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. On-body Injectors Market: Regional Estimates & Trend Analysis

• 7.1. Regional Dashboard
• 7.2. Regional On-body Injectors Market movement analysis
• 7.3. On-body Injectors Market: Regional Estimates & Trend Analysis by Technology, Application & End Use
• 7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the following
• 7.5. North America
  • 7.5.1. North America On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.2. U.S.
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Framework
    • 7.5.2.4. Reimbursement scenario
    • 7.5.2.5. U.S. On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.3. Canada
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Framework
    • 7.5.3.4. Reimbursement scenario
    • 7.5.3.5. Canada On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.5.4. Mexico
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Framework
    • 7.5.4.4. Reimbursement scenario
    • 7.5.4.5. Mexico On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.6. Europe
  • 7.6.1. Europe On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.2. UK
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Framework
    • 7.6.2.4. Reimbursement scenario
    • 7.6.2.5. UK On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.3. Germany
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Framework
    • 7.6.3.4. Reimbursement scenario
    • 7.6.3.5. Germany On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.4. France
    • 7.6.4.1. Key Country Dynamics
    • 7.6.4.2. Competitive Scenario
    • 7.6.4.3. Regulatory Framework
    • 7.6.4.4. Reimbursement scenario
    • 7.6.4.5. France On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.5. Italy
    • 7.6.5.1. Key Country Dynamics
    • 7.6.5.2. Competitive Scenario
    • 7.6.5.3. Regulatory Framework
    • 7.6.5.4. Reimbursement scenario
    • 7.6.5.5. Italy On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.6. Spain
    • 7.6.6.1. Key Country Dynamics
    • 7.6.6.2. Competitive Scenario
    • 7.6.6.3. Regulatory Framework
    • 7.6.6.4. Reimbursement scenario
    • 7.6.6.5. Spain On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.7. Denmark
    • 7.6.7.1. Key Country Dynamics
    • 7.6.7.2. Competitive Scenario
    • 7.6.7.3. Regulatory Framework
    • 7.6.7.4. Reimbursement scenario
    • 7.6.7.5. Denmark On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.8. Sweden
    • 7.6.8.1. Key Country Dynamics
    • 7.6.8.2. Competitive Scenario
    • 7.6.8.3. Regulatory Framework
    • 7.6.8.4. Reimbursement scenario
    • 7.6.8.5. Sweden On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.6.9. Norway
    • 7.6.9.1. Key Country Dynamics
    • 7.6.9.2. Competitive Scenario
    • 7.6.9.3. Regulatory Framework
    • 7.6.9.4. Reimbursement scenario
    • 7.6.9.5. Norway On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.7. Asia Pacific
  • 7.7.1. Asia Pacific On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.2. Japan
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Framework
    • 7.7.2.4. Reimbursement scenario
    • 7.7.2.5. Japan On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.3. China
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Framework
    • 7.7.3.4. Reimbursement scenario
    • 7.7.3.5. China On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.4. India
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Framework
    • 7.7.4.4. Reimbursement scenario
    • 7.7.4.5. India On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.5. South Korea
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Framework
    • 7.7.5.4. Reimbursement scenario
    • 7.7.5.5. South Korea On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.6. Australia
    • 7.7.6.1. Key Country Dynamics
    • 7.7.6.2. Competitive Scenario
    • 7.7.6.3. Regulatory Framework
    • 7.7.6.4. Reimbursement scenario
    • 7.7.6.5. Australia On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.7.7. Thailand
    • 7.7.7.1. Key Country Dynamics
    • 7.7.7.2. Competitive Scenario
    • 7.7.7.3. Regulatory Framework
    • 7.7.7.4. Reimbursement scenario
    • 7.7.7.5. Thailand On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.8. Latin America
  • 7.8.1. Latin America On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.2. Brazil
    • 7.8.2.1. Key Country Dynamics
    • 7.8.2.2. Competitive Scenario
    • 7.8.2.3. Regulatory Framework
    • 7.8.2.4. Reimbursement scenario
    • 7.8.2.5. Brazil On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.8.3. Argentina
    • 7.8.3.1. Key Country Dynamics
    • 7.8.3.2. Competitive Scenario
    • 7.8.3.3. Regulatory Framework
    • 7.8.3.4. Reimbursement scenario
    • 7.8.3.5. Argentina On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
• 7.9. Middle East & Africa
  • 7.9.1. Middle East & Africa On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.2. South Africa
    • 7.9.2.1. Key Country Dynamics
    • 7.9.2.2. Competitive Scenario
    • 7.9.2.3. Regulatory Framework
    • 7.9.2.4. Reimbursement scenario
    • 7.9.2.5. South Africa On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.3. Saudi Arabia
    • 7.9.3.1. Key Country Dynamics
    • 7.9.3.2. Competitive Scenario
    • 7.9.3.3. Regulatory Framework
    • 7.9.3.4. Reimbursement scenario
    • 7.9.3.5. Saudi Arabia On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.4. UAE
    • 7.9.4.1. Key Country Dynamics
    • 7.9.4.2. Competitive Scenario
    • 7.9.4.3. Regulatory Framework
    • 7.9.4.4. Reimbursement scenario
    • 7.9.4.5. UAE On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 7.9.5. Kuwait
    • 7.9.5.1. Key Country Dynamics
    • 7.9.5.2. Competitive Scenario
    • 7.9.5.3. Regulatory Framework
    • 7.9.5.4. Reimbursement scenario
    • 7.9.5.5. Kuwait On-body Injectors Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Market Participant Categorization
• 8.2. Key Company Profiles
  • 8.2.1. West Pharmaceutical Services, Inc.
    • 8.2.1.1. Company overview
    • 8.2.1.2. Financial performance
    • 8.2.1.3. Product benchmarking
    • 8.2.1.4. Strategic initiatives
  • 8.2.2. BD
    • 8.2.2.1. Company overview
    • 8.2.2.2. Financial performance
    • 8.2.2.3. Product benchmarking
    • 8.2.2.4. Strategic initiatives
  • 8.2.3. Stevanato Group
    • 8.2.3.1. Company overview
    • 8.2.3.2. Financial performance
    • 8.2.3.3. Product benchmarking
    • 8.2.3.4. Strategic initiatives
  • 8.2.4. Enable Injections
    • 8.2.4.1. Company overview
    • 8.2.4.2. Financial performance
    • 8.2.4.3. Product benchmarking
    • 8.2.4.4. Strategic initiatives
  • 8.2.5. Nemera
    • 8.2.5.1. Company overview
    • 8.2.5.2. Financial performance
    • 8.2.5.3. Product benchmarking
    • 8.2.5.4. Strategic initiatives
  • 8.2.6. Debiotech SA
    • 8.2.6.1. Company overview
    • 8.2.6.2. Financial performance
    • 8.2.6.3. Product benchmarking
    • 8.2.6.4. Strategic initiatives
  • 8.2.7. AbbVie, Inc.
    • 8.2.7.1. Company overview
    • 8.2.7.2. Financial performance
    • 8.2.7.3. Product benchmarking
    • 8.2.7.4. Strategic initiatives
  • 8.2.8. Coherus BioSciences, Inc.
    • 8.2.8.1. Company overview
    • 8.2.8.2. Financial performance
    • 8.2.8.3. Product benchmarking
    • 8.2.8.4. Strategic initiatives
  • 8.2.9. Gerresheimer AG
    • 8.2.9.1. Company overview
    • 8.2.9.2. Financial performance
    • 8.2.9.3. Product benchmarking
    • 8.2.9.4. Strategic initiatives
  • 8.2.10. E3D Elcam Drug Delivery Devices
    • 8.2.10.1. Company overview
    • 8.2.10.2. Financial performance
    • 8.2.10.3. Product benchmarking
    • 8.2.10.4. Strategic initiatives